Analysis of naïve Patients With Age-related Macular Degeneration Neovascular Type and Treated With Ranibizumab (Lucentis®) in Treat-and-extend at the CHU Brugmann.
Clinical trial NCT04988178 · COMPLETED
Trial details
- NCT number
- NCT04988178
- Sponsor
- Brugmann University Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-04-13
- Primary completion
- 2021-09-22
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.